Future Retirement Success
  • Politics
  • Business
  • Investing
  • Stocks
  • Politics
  • Business
  • Investing
  • Stocks

Future Retirement Success

Investing

The Myth of the Free-Market US Health Sector

by May 13, 2024
May 13, 2024
The Myth of the Free-Market US Health Sector

Michael F. Cannon

Rena Conti, Richard Frank, and David Cutler recently published a very useful piece in the New England Journal of Medicine under the title, “The Myth of the Free Market for Pharmaceuticals.” Conti, Frank, and Cutler shatter the common myths that the United States has “largely unregulated prices” for medical care (Los Angeles Times) or is “one of the only developed countries where health care is left mostly to the free market” (The Economist).

The authors detail multiple ways that government intervenes in and distorts the pharmaceutical market and conclude, “The net effect of these deviations from the free‐​market ideal is that prices are high.” When drug manufacturers like Merck claim, “Congress has long been committed to a free‐​market approach based on market‐​driven prices,” these producers are merely trying to protect the government interventions that let them charge higher prices than would prevail in a free market.

This problem is not unique to the pharmaceutical industry but pervades the entire US health sector. In the new Cato Institute book The War on Prices (release date May 14), I contribute a chapter with the title, “Government Price Fixing Is the Rule in U.S. Health Care.” I explain that—contrary to industry propaganda that holds government price controls only result in inefficiently low prices—US medical prices are often high because government controls them. For example, “studies conducted in the USA generally conclude that price setting by a regulator…improved hospital financial stability.”

Remember that the next time the hospital lobby comes calling.

Still, it’s hard not to quibble with what Conti, Frank, and Cutler describe as some of the features of free markets.

When they write, “In free markets, consumers are assumed to be fully informed,” the passive voice betrays that they are conflating the concept of real‐​world free markets with the theoretical concept of perfectly competitive markets. Free markets can and do exist. In contrast, there are few markets, if any, that satisfy all the requirements for perfect competition. To conflate the two deprives the term free market of utility.

It is likewise imprecise to enumerate that drug ads “are often misleading,” that “most consumers are insured,” or that “doctors may be financially rewarded for using more expensive drugs even when less expensive drugs are equally effective” as among the pharmaceutical market’s “deviations from the free‐​market ideal.” As much as I like the authors’ main conclusion, misleading advertising, health insurance, and conflicts of interest would all exist in a free market. Indeed, misleading advertisements might indicate the market is too free because government is not doing its job of preventing producers from using fraud to overcome the will of consumers.

0
FacebookTwitterGoogle +Pinterest
previous post
This is the #1 Options Income Strategy You Should Master
next post
People v. Armstrong Brief: Marijuana Odor Can’t Be Probable Cause Where It’s Legal

You may also like

Does Higher Education Need “Saving”?

March 22, 2025

SCOTUS Has a Chance to Rein in Civil...

February 21, 2025

Trump v. US: With Great Power Comes Great...

July 11, 2024

Warren, Trump, and the Debt Limit

June 25, 2025

The Benefits of China’s Market Reforms and Opening...

October 11, 2023

Join Us in Person or Online, Sept. 7...

September 5, 2023

The First Step Act Applies to Resentenced Defendants

May 6, 2024

Australians and Septic Tank Yanks

July 10, 2023

The Untouchables: How Prosecutorial Immunity Breeds Injustice

March 11, 2025

Yard-Sign Libertarianism and Kamalamania

August 20, 2024

    Get free access to all of the retirement secrets and income strategies from our experts! or Join The Exclusive Subscription Today And Get the Premium Articles Acess for Free

    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Recent Posts

    • What Should We Learn from China’s Nuclear Construction Costs?

      August 7, 2025
    • Closing the Primary Care Gap

      August 7, 2025
    • Veteran Biden insider Anita Dunn appears in House Oversight autopen probe

      August 7, 2025
    • NDAs banning harassment and discrimination disclosures to be void under new UK workplace reforms

      August 7, 2025
    • Bank of England cuts interest rates to 4% in historic two-round vote amid economic slowdown

      August 7, 2025
    • Trump-Putin meeting agreed upon ‘in principle,’ Kremlin aide indicates

      August 7, 2025

    Categories

    • Business (8,703)
    • Investing (2,181)
    • Politics (16,331)
    • Stocks (3,228)
    • About us
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: futureretirementsuccess.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2025 futureretirementsuccess.com | All Rights Reserved